Blood News and Research

RSS

UCLA receives nearly $14 million NIH grant to investigate immunotherapy to destroy HIV

UCLA researchers and colleagues have received a $13.65 million grant from the National Institutes of Health to investigate and further develop an immunotherapy known as CAR T, which uses genetically modified stem cells to target and destroy HIV.

16 Jun 2020

Australian program helps keep young cancer patients with a fever at home

An Australian program that avoids hospital admission for some young cancer patients with a fever is helping to ease pressure on the UK health system during the COVID-19 crisis.

16 Jun 2020

Combination of antibodies and internal radiation can help fight cervical cancer

The sugar coating on cancer cells helps them thrive, and a new study indicates patients with cervical cancer who make antibodies to those sugars appear to do better when they also receive internal radiation therapy.

16 Jun 2020

Study shows lean beef does not adversely affect diabetes and heart health

Results from a new study show that risk factors for cardiovascular disease and diabetes were similar when participants consumed a healthy US-style eating pattern with and without an additional 5.3 ounces of lean beef.

16 Jun 2020

Sending discharge letters to patients can make major difference to patient outcomes

Sending discharge letters to patients as well as their GPs when they leave hospital could make a substantial difference to patient outcomes, according to a new study by University of Warwick researchers.

16 Jun 2020

Cholesterol levels are declining in western countries but rising in Asia

Cholesterol levels are declining sharply in western nations, but rising in low- and middle-income nations - particularly in Asia, according to a study of global cholesterol levels, which involve researchers at the University of Gothenburg.

16 Jun 2020

Why improved pneumonia diagnosis is needed now more than ever

News-Medical speaks to Dr. William La Via about why improved pneumonia diagnosis is vital, especially in the wake of the COVID-19 pandemic.

16 Jun 2020

Cell signaling pathway could treat chronic kidney disease and other medical conditions

Scientists have discovered an important cell signaling pathway in the kidney which if stopped, could hold the key to treating chronic kidney disease as well as other deadly conditions, including heart attack and stroke.

16 Jun 2020

Study shows high folate levels associated with improved cognition in older adults

A new study led by researchers from The Irish Longitudinal Study on Ageing (TILDA) at Trinity College Dublin challenges claims from some international scientific circles, that having high blood levels of folate (folic acid) increases the risk of poor cognition in older adults, especially in those with low levels of vitamin B12.

16 Jun 2020

Blood vessels can sense the metabolic state of neighboring neural cells, shows study

The brain is our most energy-hungry and metabolically active organ. It is responsible for our thoughts, ideas, movement and ability to learn.

16 Jun 2020

Scientists develop molecules that can remodel gut bacteria to a healthier state

Scientists at Scripps Research have developed molecules that can remodel the bacterial population of intestines to a healthier state and they have shown--through experiments in mice--that this reduces cholesterol levels and strongly inhibits the thickened-artery condition known as atherosclerosis.

16 Jun 2020

New model predicts patients’ likelihood of testing positive for COVID-19

Cleveland Clinic researchers have developed the world's first risk prediction model for healthcare providers to forecast an individual patient's likelihood of testing positive for COVID-19 as well as their outcomes from the disease.

16 Jun 2020

A new technology to print 3D tissues directly in the body

In the TV series Westworld, human body parts are built on robotic frames using 3D printers. While still far from this scenario, 3D printers are being increasingly used in medicine.

15 Jun 2020

Human antibodies provide powerful protection against SARS-CoV-2 in animal tests

A team led by Scripps Research has discovered antibodies in the blood of recovered COVID-19 patients that provide powerful protection against SARS-CoV-2, the coronavirus that causes the disease, when tested in animals and human cell cultures.

15 Jun 2020

Apotex recalls some Metformin batches due to possible carcinogen

Metformin, a prescription drug for people with type II diabetes, helps maintain blood glucose levels. Apotex Inc., a Canadian pharmaceutical corporation, is voluntarily recalling some batches of its metformin drug, sold under the brand name APO-Metformin ER (extended-release).

15 Jun 2020

Millimeter-thick cell-laden hydrogel fiber helps control blood glucose in diabetic mice

Type 1 diabetes mellitus results from an irreversible autoimmune destruction of insulin-producing pancreatic β-cells requiring life-long substitution of insulin.

15 Jun 2020

Breakthrough drug significantly delays onset of type 1 diabetes, study finds

Emily Sims, M.D. today shared new findings that a breakthrough drug significantly delays the onset of type 1 diabetes (T1D).

15 Jun 2020

Genetic marker may predispose African Americans to cardiac complications from COVID-19

Nearly one out of every 10 African Americans has a genetic variant that puts them inherently at an increased risk for ventricular arrhythmias and sudden cardiac death.

15 Jun 2020

Irregular circadian rhythm in older adults associated with increased risk of Parkinson's disease

Older men who have a weak or irregular circadian rhythm guiding their daily cycles of rest and activity are more likely to later develop Parkinson's disease, according to a new study by scientists at the UC San Francisco Weill Institute for Neurosciences who analyzed 11 years of data for nearly 3,000 independently living older men.

15 Jun 2020

Experimental drug to prevent deadly blood coagulation in patients with COVID-19

The British Heart Foundation is funding a trial for an experimental drug that could prevent the life-threatening blood clots that are seen in the lungs of the patients with COVID-19 or those infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The drug named TRV027 is said to normalize the hormonal imbalance that can be seen in patients developing COVID-19, experts said.

15 Jun 2020

Blood News and Research

UCLA receives nearly $14 million NIH grant to investigate immunotherapy to destroy HIV

Australian program helps keep young cancer patients with a fever at home

Combination of antibodies and internal radiation can help fight cervical cancer

Study shows lean beef does not adversely affect diabetes and heart health

Sending discharge letters to patients can make major difference to patient outcomes

Cholesterol levels are declining in western countries but rising in Asia

Why improved pneumonia diagnosis is needed now more than ever

Cell signaling pathway could treat chronic kidney disease and other medical conditions

Study shows high folate levels associated with improved cognition in older adults

Blood vessels can sense the metabolic state of neighboring neural cells, shows study

Scientists develop molecules that can remodel gut bacteria to a healthier state

New model predicts patients’ likelihood of testing positive for COVID-19

A new technology to print 3D tissues directly in the body

Human antibodies provide powerful protection against SARS-CoV-2 in animal tests

Apotex recalls some Metformin batches due to possible carcinogen

Millimeter-thick cell-laden hydrogel fiber helps control blood glucose in diabetic mice

Breakthrough drug significantly delays onset of type 1 diabetes, study finds

Genetic marker may predispose African Americans to cardiac complications from COVID-19

Irregular circadian rhythm in older adults associated with increased risk of Parkinson's disease

Experimental drug to prevent deadly blood coagulation in patients with COVID-19

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News